Select Page

Home / Share Price Target / Sparc

Sun Pharma Advanced Research Company Share Price Target 2024, 2025, 2026 to 2039 With Charts

Sun Pharma Advanced Research Company Limited

Company LogoSymbol: SPARC
Price: ₹234.27
Exchange: NSE
Healthcare -> Drug Manufacturers - Specialty & Generic
Show Table of Contents

Sun Pharma Advanced Research Company Brief Company Overview

Overview of Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited is a leading biopharmaceutical company dedicated to research and development of innovative pharmaceutical products. Founded in 2006 and headquartered in Mumbai, India, the company has a strong presence in India and internationally.

Sun Pharma Advanced Research is renowned for its diverse product portfolio, with a focus on therapeutics for oncology, neurodegeneration, ophthalmology, dermatology, and immunology.

Notable Products

  • Elepsia XR (anti-epileptic)
  • Xelpros (glaucoma treatment)
  • Phenobarbital injection (neonatal seizures)

Development Pipeline

The company is committed to expanding its product range through ongoing research and development. Some key pipeline candidates include:

  • SDN-037 (ocular surgery inflammation)
  • PDP-716 (glaucoma)
  • Vodobatinib (chronic myelogenous leukemia and Parkinson's disease)
  • SCD-044 (psoriasis and atopic dermatitis)
  • SCO-120 (breast cancer)

Advertisement

Sun Pharma Advanced Research Company Financial Performance

MetricValueDescription
Market Capital7,019.41 CroreMarket valuation of Sun Pharma Advanced Research Company's shares.
Revenue (TTM)106.68 CroreTotal revenue generated by Sun Pharma Advanced Research Company over the past twelve months.
Net Income (TTM)-363.41 CroreNet Profit or Loss after all the expenses over the past twelve months.
Operating Margin-763.21%Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin28.14%Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
-89.4%Change in revenue compared to the previous quarter.
Debt-to-Equity
(D/E) Ratio
4.28Company's total debt divided by total shareholder equity.
Total Debt14.21 CroreSum of Sun Pharma Advanced Research Company's current & long-term financial obligations.
Total Cash366.09 CroreTotal amount of liquid funds available to Sun Pharma Advanced Research Company.
Beta0.74Beta is less than 1 indicating that the Sun Pharma Advanced Research Company's price is less volatile than the market.

Is Sun Pharma Advanced Research Company A Good Buy For Long Term?

Despite a recent revenue decline and a negative profit margin, Sun Pharma Advanced Research Company has historically delivered positive returns over the long term. With a revenue of 106.68 Crore, a net profit of -363.41 Crore, and a market cap of 7,257.93 Crore, the company's financials warrant caution. Its recent -89.4% revenue change compared to the previous quarter raises concerns. However, its past performance suggests potential for long-term growth.

To predict the Sun Pharma Advanced Research Company's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

Sun Pharma Advanced Research Company Share Price Target For 2024

 Sun Pharma Advanced Research Company Targets For 2024 Chart

The line chart displays the monthly closing prices of Sun Pharma Advanced Research Company with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Sun Pharma Advanced Research Company shares in 2024, see the table below.

Advertisement

Sun Pharma Advanced Research Company Share Price Target Table For 2024

Sun Pharma Advanced Research Company's LevelsValueReason/Importance
2024 Target 3282.59 (+20.62%)Price Action: Chart
2024 Target 2277.32 (+18.37%)Price Action: Chart
2024 Target 1274.57 (+17.2%)Technical Indicator: MA50
Current Price234.27 Sun Pharma Advanced Research Company's 1 share price as of Fri 14 Jun 2024
Stop Loss 1218.85 (-6.59%)Price Action: 07 Jun 2024 Low
Stop Loss 2216.35 (-7.65%)Price Action: Aug 2023 Low
Stop Loss 3214.14 (-8.6%)Price Action: 21 May 2024 Low

Summary: Sun Pharma Advanced Research Company Share Price Prediction For 2024

In summary, Sun Pharma Advanced Research Company has declined by ₹-52.53, recording a notable -18.32% decrease from 1st January 2024 to 14 Jun 2024. Despite the setback, our analysis of Sun Pharma Advanced Research Company for 2024 predicts an additional rise of 17.2% to 20.62% by the end of 2024 with three potential targets T1: 274.57, T2: 277.32, T3: 282.59. Stop Loss at SL1: 218.85, SL2: 216.35, SL3: 214.14.

Sun Pharma Advanced Research Company has a 52-week high of ₹472.79, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹189.64, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's share price prediction, let's now check what 2025 might hold for Sun Pharma Advanced Research Company.

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Sun Pharma Advanced Research Company Share Price Target For 2025

 Sun Pharma Advanced Research Company Targets For 2025 Chart

The line chart displays the monthly closing prices of Sun Pharma Advanced Research Company with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Sun Pharma Advanced Research Company shares in 2025, see the table below.

Advertisement

Sun Pharma Advanced Research Company Share Price Target Table For 2025

Sun Pharma Advanced Research Company's LevelsValueReason/Importance
2025 Target 3415.33 (+77.28%)Price Action: Chart
2025 Target 2407.59 (+73.98%)Price Action: Chart
2025 Target 1403.55 (+72.25%)Custom Fibonacci Extension Lvl 64.9%
Current Price234.27 Sun Pharma Advanced Research Company's 1 share price as of Fri 14 Jun 2024
Stop Loss 1192.71 (-17.75%)Price Action: Chart
Stop Loss 2190.78 (-18.57%)Price Action: Chart
Stop Loss 3187.35 (-20.03%)Price Action: Chart

Summary: Sun Pharma Advanced Research Company Share Price Prediction For 2025

In summary, Sun Pharma Advanced Research Company has declined by ₹-52.53, recording a notable -18.32% decrease from 1st January 2024 to 14 Jun 2024. Despite the setback, our analysis of Sun Pharma Advanced Research Company for 2025 predicts an additional rise of 72.25% to 77.28% by the end of 2025 with three potential targets T1: 403.55, T2: 407.59, T3: 415.33. Stop Loss at SL1: 192.71, SL2: 190.78, SL3: 187.35.

Sun Pharma Advanced Research Company has a All-Time high of ₹593.95, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹189.64, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Sun Pharma Advanced Research Company, we have created a specific page for that check here: Sun Pharma Advanced Research Company Share Price Target For Tomorrow & Next Week

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

Sun Pharma Advanced Research Company Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039

 Sun Pharma Advanced Research Company Targets Chart 2024, 2025, 2026 to 2039

This chart presents a detailed projection of Sun Pharma Advanced Research Company share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of -0.62% over the next 15 years.

For complete year by year Sun Pharma Advanced Research Company long term share price target from 2024, 2025 to 2039 check the below table.

Sun Pharma Advanced Research Company Share Price Target Table From 2024, 2025, 2026 to 2039

Year Sun Pharma Advanced Research Company TargetYoY Change %
2024₹234.27[Current Price]
2024₹260.4511.17%
2025₹257.43-1.16%
2026₹264.022.56%
2027₹248.55-5.87%
2028₹270.198.7%
2029₹250.62-7.25%
2030₹247.63-1.2%
2031₹253.912.53%
2032₹238.95-5.9%
2033₹259.668.66%
2034₹240.78-7.28%
2035₹237.84-1.23%
2036₹243.782.49%
2037₹229.34-5.93%
2038₹249.148.63%
2039₹238.72-4.19%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Sun Pharma Advanced Research Company Past Performance

SPARC main
Sun Pharma Advanced Research Company has been listed on NSE for more than 17 years.
  • In 2007, Sun Pharma Advanced Research Company opening price was ₹90.86
  • As of Fri 14 Jun 2024 the price stands at ₹234.27.
  • This represents a Compound Annual Growth Rate (CAGR) of 5.4%.
  • In 17 years, an investment of 10,000 would have become ₹25,783.62.

As we wrap up, we hope you like our study on Sun Pharma Advanced Research Company share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.

Show Methodology We Use

Methodology Behind the Prediction

The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.

We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.

For more insights into Sun Pharma Advanced Research Company Limited, explore these additional resources:-

Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.

About The Author

Nippun

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, and let’s learn from each other. My Twitter